Gritstone Announces Dosing of First Volunteer in Trial Evaluating Self-Amplifying mRNA as a COVID-19 Vaccine Booster and Immunogenicity Enhancer

NEXT STORY
BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical Oncology (ESMO) 2021 Congress
PREV STORY
Apellis Pharmaceuticals to Present at the 2021 Cantor Virtual Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Biopharma to Present at the Oppenheimer Houston Oncology Summit at the University of Texas MD Anderson Cancer Center

author_avatar
NASDAQ Market News

MPX INTERNATIONAL ANNOUNCES VIRTUAL CONSULTATION TO SUPPORT MEDICAL CANNABIS PATIENTS DURING COVID-19

author_avatar
NASDAQ Market News

Vaxart to Participate at the H.C. Wainwright BioConnect Virtual Conference

author_avatar
NASDAQ Market News